Skip to main content
Glama

get_adverse_events

Read-only

FDA FAERS adverse-event signal: total and serious report counts and top MedDRA reactions with report counts (spontaneous reports, not incidence). (free daily allowance, then paid: $0.05 USDC via x402, or 3 credit(s) with X-API-KEY)

Input Schema

NameRequiredDescriptionDefault
slugYesPeptide slug

Schema Changelog

Changes observed during successful MCP inspections.

  1. Added

TDQS

A3.7/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already cover the safety profile (readOnlyHint=true, openWorldHint=false), so the bar is lower, and the description still adds real context: the counts are spontaneous reports, not incidence — a genuine interpretive caveat that prevents misuse. It also discloses the auth/billing model (free daily allowance, then $0.05 USDC via x402 or 3 credits with X-API-KEY), which matters for invocation planning. It stops short of noting recency or reporting-bias limits.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Two sentences, front-loaded with the data source and return shape, then the caveat, then the billing parenthetical. The pricing clause is boilerplate but genuinely actionable, so little is wasted; the payload is dense and well ordered.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the return-shape burden and does so: total counts, serious counts, and top MedDRA reactions with counts. Since only one fully-documented parameter exists and safety annotations are present, remaining gaps are minor — how many 'top' reactions are returned and whether a time window applies are unstated.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100% for the single 'slug' parameter, so the schema already carries the semantics. The description adds nothing about the slug (format, where to obtain it), leaving it at the baseline for a fully-documented single parameter.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb-resource pair and data source: 'FDA FAERS adverse-event signal' returning total and serious report counts plus top MedDRA reactions. It is clear what an agent gets back, but it never separates itself from the sibling get_safety, which is a plausible alternative for the same underlying need.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines3/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Usage is only implied by the data source ('FDA FAERS adverse-event signal') — an agent infers this is the safety-signal lookup rather than a trial or regulatory lookup. There is no explicit when-to-use, no exclusion, and no mention of when get_safety or get_approvals would be the better pick.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

Resources